Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|MF tricyclic||MF tricyclic is a COX-2 inhibitor that may reduce tumor burden and prevent metastasis in cancer (PMID: 16003752, PMID: 17213821).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|APC inact mut||colon cancer||sensitive||MF tricyclic||Preclinical||Actionable||In a preclinical study, mouse models of colon cancer carrying an APC 716del mutation had reduced polyp formation after treatment with MF tricyclic (PMID: 23843721).||23843721|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|